closed up again, page-2

Main game here is Lani v Tamiflu....specifically the need to replace $8b around the world - of "out of date" Tamiflu.

Who knows when Lani will reach the market place.....but every, every indication is, that it will.

Tamiflu can't compete.

Anti-viral drugs Relenza and Tamiflu ideally must be taken over a five day period (twice a day)...and commenced with 48 hours of influenza onset.

Lani one puff - to start feeling better.

Aside from Government stockiling....My family/friends do not currently stock either of the current antivirals....but what a difference a single, simpler, more effective puffer devise would make....ie LANI
------------------------------------------------

Should Lani reach the market place.....it will be a SENSATION. World Government ptreference for LANI...as was the case with Tamiflu over Relenza - may see forwrd earnings maybe of $200m PA....or market cap $1.4 b or $8 per share.

Its not a problem for me to wait, because of likely 600% returns on this one.